Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06885203

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors.

A community-based and peer-led Black Breast Cancer Survivor's Intervention (BBCSI) course has been developed to help improve the quality of life of Black breast cancer survivors.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Dede Teteh-Brooks, DRPH

CONTACT

[email protected]

713-563-3493

Dede Teteh-Brooks, DRPH

PRINCIPAL_INVESTIGATOR

About this study

Primary Objectives:

Develop a prototype of the BBCSI curriculum and assess satisfaction of the intervention.

Determine the preliminary efficacy of the BBCSI.

Evaluate fidelity, feasibility, acceptability, barriers, and facilitators of the BBCSI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Master Trainers:

To be eligible to participate in this study, an individual must meet all the following criteria:

  • Adult women aged 18 years and older
  • Histologically confirmed stage 0-III breast cancer
  • No evidence of metastatic disease
  • Self-identify as Black
  • Able to communicate in English

Participants:

To be eligible to participate in this study, an individual must meet all the following criteria:

  • Adult women aged 18 years and older
  • Histologically confirmed stage 0-III breast cancer
  • No evidence of metastatic disease
  • Self-identify as Black
  • Able to communicate in English

Community Interventionists:

To be eligible to participate in this study, an individual must meet all the following criteria:

  • Adult women aged 18 years and older
  • Histologically confirmed stage 0-III breast cancer
  • No evidence of metastatic disease
  • Self-identify as Black
  • Former study participants that have completed the intervention
  • Able to communicate in English

General Exclusion Criteria:

  • Men or woman below 18 years of age
  • Does not have a histologically confirmed breast cancer
  • There's evidence of metastatic disease
  • Does not self-identify as Black
  • Unable to communicate in English

Additional Exclusion Criteria - Community Interventionists

  • Has not previously participated in and completed the study intervention as a participant

Treatment and study plan

Black Breast Cancer Survivor's Intervention

Behavioral

Participants will complete the BBCSI course (1-hour virtual sessions every week for 6 weeks), answer questionnaires before and after the course, and provide urine samples.

Primary outcomes

  1. Safety and Adverse Events (AEs)

    Time frame: Time Frame: Through study completion; an average of 1 year

    Safety and Adverse Events (AEs)

Study contacts

Contact information is provided by the study sponsor or research team.

Dede Teteh-Brooks, DRPH

CONTACT

[email protected]

713-563-3493

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2029
First posted
Mar 20, 2025
Registry last updated
Aug 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.